Study #ALLIANCE-A221702
ALLIANCE-A221702: ARM: Axillary Reverse Mapping - A Prospective Trial to Study Rates of Lymphedema and Regional Recurrence after Sentinel Lymph Node Biopsy and Sentinel Lymph Node Biopsy Followed by Axillary Lymph Node Dissection with and without Axillary
MD Anderson Study Status
Not Accepting
Treatment Agent
Isosulfan Blue
Description
This phase III trial studies how well axillary reverse mapping works in preventing lymphedema in patients with breast cancer undergoing axillary lymph node dissection. Axillary reverse mapping may help to preserve the lymph node drainage system around the breast so as to prevent lymphedema after surgery.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III
Study phase:
Phase III
Physician name:
Sarah DeSnyder
Department:
Breast Surgical Oncology
For general questions about clinical trials:
1-855-508-2908
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.